Humoral factors in ALS patients during disease progression

Area of Science:

• Neuroscience
• Immunology
• Biochemistry

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no effective treatments.
• Understanding systemic factors in ALS progression is crucial for biomarker discovery.
• The study aimed to identify humoral effectors reflecting ALS pathological developments.

Purpose of the Study:

• To identify humoral factors as potential biomarkers for Amyotrophic Lateral Sclerosis (ALS) during disease progression.
• To investigate systemic changes in cytokines, nitrite, and glutathione levels in ALS patients.

Main Methods:

• Analyzed serum samples from 13 ALS patients and 7 controls at two 6-month intervals.
• Measured cytokine levels (IL-2, IL-5, IL-6, IL-8, etc.) using multiplex assay.
• Quantified nitrite and glutathione (GSH) concentrations.

Main Results:

• ALS patients showed disease progression (ALSFRS-R scores decreased).
• Significant changes in IL-2, IL-5, IL-6, and IL-8 levels were observed in ALS patients.
• ALS patients exhibited elevated nitrite and drastically decreased GSH levels compared to controls.

Conclusions:

• ALS patients display a systemic pro-inflammatory state and impaired antioxidant system.
• Elevated IL-6, IL-8, nitrite, and decreased GSH are potential systemic biomarkers for ALS.
• Dynamic changes in humoral factors suggest adaptive immune responses and potential therapeutic targets.